These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 33480186)

  • 1. Complications of left ventricular assist devices causing high urgency status on waiting list: impact on outcome after heart transplantation.
    Immohr MB; Boeken U; Mueller F; Prashovikj E; Morshuis M; Böttger C; Aubin H; Gummert J; Akhyari P; Lichtenberg A; Schramm R
    ESC Heart Fail; 2021 Apr; 8(2):1253-1262. PubMed ID: 33480186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of new-generation intrapericardial continuous flow left ventricular assist devices as a bridge-to-transplant.
    Carrozzini M; Bejko J; Gambino A; Tarzia V; Lanera C; Gregori D; Gerosa G; Bottio T
    J Cardiovasc Med (Hagerstown); 2018 Dec; 19(12):739-747. PubMed ID: 30300244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of high-urgency heart transplant patients with and without temporary ventricular assist device support.
    Castel MA; Cartañá R; Cardona M; Pereda D; Hernández M; Sandoval E; Castella M; Pérez-Villa F
    Transplant Proc; 2012 Nov; 44(9):2642-4. PubMed ID: 23146481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging roles of left ventricular assist device therapy as bridge to transplant in an Asian city with scarce heart transplant donor.
    Wong KL; Ho KLC; Lee OJ; Lun KS; Bhatia I; Tam WYE; Fan YYK; Au WKT
    J Thorac Dis; 2021 Oct; 13(10):5717-5730. PubMed ID: 34795921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of insurance status on heart transplant wait-list mortality for patients with left ventricular assist devices.
    Emani S; Tumin D; Foraker RE; Hayes D; Smith SA
    Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 27862317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality.
    Truby LK; Farr MA; Garan AR; Givens R; Restaino SW; Latif F; Takayama H; Naka Y; Takeda K; Topkara VK
    Circulation; 2019 Aug; 140(6):459-469. PubMed ID: 31203669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of using higher-risk donor hearts for candidates with pre-transplant mechanical circulatory support.
    Han J; Moayedi Y; Yang W; Henricksen EJ; Lee R; Purewal S; Chang E; Duclos S; Lyapin A; Feng K; Hiesinger W; Teuteberg JJ; Khush KK
    J Heart Lung Transplant; 2022 Feb; 41(2):237-243. PubMed ID: 34815161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac replacement therapies: outcomes and costs for heart transplantation versus circulatory assist.
    Mishra V; Fiane AE; Winsnes BA; Geiran O; Sørensen G; Hagen TP; Gude E
    Scand Cardiovasc J; 2017 Feb; 51(1):1-7. PubMed ID: 27248460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation.
    Ammirati E; Oliva FG; Colombo T; Russo CF; Cipriani MG; Garascia A; Guida V; Colombo G; Verde A; Perna E; Cannata A; Paino R; Martinelli L; Frigerio M
    Heart Vessels; 2016 May; 31(5):722-33. PubMed ID: 25735775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term heart transplant outcomes after lowering fixed pulmonary hypertension using left ventricular assist devices.
    Moayedifar R; Zuckermann A; Aliabadi-Zuckermann A; Riebandt J; Angleitner P; Dimitrov K; Schloeglhofer T; Rajek A; Laufer G; Zimpfer D
    Eur J Cardiothorac Surg; 2018 Dec; 54(6):1116-1121. PubMed ID: 29905775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant.
    Trivedi JR; Cheng A; Singh R; Williams ML; Slaughter MS
    Ann Thorac Surg; 2014 Sep; 98(3):830-4. PubMed ID: 25087934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-Year Clinical Outcome after Left Ventricular Assist Device Malfunction.
    Oezpeker UC; Zittermann A; Erkilet G; Schulz U; Ensminger S; Gummert JF; Morshuis M
    Thorac Cardiovasc Surg; 2015 Dec; 63(8):663-9. PubMed ID: 25938270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure.
    Schumer EM; Ising MS; Trivedi JR; Slaughter MS; Cheng A
    Ann Thorac Surg; 2015 Aug; 100(2):522-7. PubMed ID: 26070601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?
    Wever-Pinzon O; Drakos SG; Kfoury AG; Nativi JN; Gilbert EM; Everitt M; Alharethi R; Brunisholz K; Bader FM; Li DY; Selzman CH; Stehlik J
    Circulation; 2013 Jan; 127(4):452-62. PubMed ID: 23271796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National trends and outcomes in device-related thromboembolic complications and malfunction among heart transplant candidates supported with continuous-flow left ventricular assist devices in the United States.
    Wever-Pinzon O; Naka Y; Garan AR; Takeda K; Pan S; Takayama H; Mancini DM; Colombo P; Topkara VK
    J Heart Lung Transplant; 2016 Jul; 35(7):884-92. PubMed ID: 27151597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of early versus delayed timing of left ventricular assist device implantation as a bridge-to-transplantation: An analysis of the UNOS dataset.
    Kitada S; Schulze PC; Jin Z; Clerkin K; Homma S; Mancini DM
    Int J Cardiol; 2016 Jan; 203():929-935. PubMed ID: 26618255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Systemic and Device-Related Complications in Patients Bridged to Transplantation With Left Ventricular Assist Devices.
    Lui C; Suarez-Pierre A; Zhou X; Crawford TC; Fraser CD; Giuliano K; Hsu S; Higgins RS; Zehr KJ; Whitman GJ; Choi CW; Kilic A
    J Surg Res; 2020 Feb; 246():207-212. PubMed ID: 31605947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.